Bank of America Securities Sticks to Their Sell Rating for Doximity (DOCS)

Bank of America Securities analyst Allen Lutz maintained a Sell rating on Doximity (DOCSResearch Report) on January 26 and set a price target of $27.00. The company’s shares closed last Friday at $34.95.

According to TipRanks, Lutz is ranked #4463 out of 8269 analysts.

Currently, the analyst consensus on Doximity is a Moderate Buy with an average price target of $39.22.

See today’s best-performing stocks on TipRanks >>

Based on Doximity’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $102.19 million and a net profit of $26.3 million. In comparison, last year the company earned a revenue of $79.35 million and had a net profit of $36.09 million

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Doximity Inc is a digital platform for U.S. medical professionals. Its cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers.

Read More on DOCS:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More